Efficacy and safety of efalizumab for scalp psoriasis: Results from a prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

doi:10.1016/j.jaad.2007.10.590

Efficacy and safety of efalizumab for scalp psoriasis: Results from a prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2007.10.590 ◽

2008 ◽

Vol 58 (2) ◽

pp. AB134

Keyword(s):

Clinical Trial ◽

Latin America ◽

Efficacy And Safety ◽

Open Label ◽

Scalp Psoriasis ◽

Phase Iiib ◽

Open Label Phase

Download Full-text

Efficacy and safety of efalizumab in adults with moderate to severe plaque psoriasis and hand and foot involvement: A prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2007.10.578 ◽

2008 ◽

Vol 58 (2) ◽

pp. AB131

Keyword(s):

Clinical Trial ◽

Latin America ◽

Plaque Psoriasis ◽

Efficacy And Safety ◽

Open Label ◽

Severe Plaque Psoriasis ◽

Phase Iiib ◽

Open Label Phase

Download Full-text

Efficacy of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective, 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2007.10.586 ◽

2008 ◽

Vol 58 (2) ◽

pp. AB133

Keyword(s):

Clinical Trial ◽

Latin America ◽

Plaque Psoriasis ◽

Open Label ◽

Severe Plaque Psoriasis ◽

Phase Iiib ◽

Open Label Phase

Download Full-text

Safety of efalizumab for the treatment of moderate to severe plaque psoriasis: A prospective 24-week, open-label phase IIIb/IV clinical trial in patients from Latin America

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2007.10.591 ◽

2008 ◽

Vol 58 (2) ◽

pp. AB134

Keyword(s):

Clinical Trial ◽

Latin America ◽

Plaque Psoriasis ◽

Open Label ◽

Severe Plaque Psoriasis ◽

Phase Iiib ◽

Open Label Phase

Download Full-text

302. ALEMTUZUMAB FOR RELAPSING AND REFRACTORY PRIMARY SYSTEMIC VASCULITIS – A TRIAL OF EFFICACY AND SAFETY (ALEVIATE): A RANDOMISED OPEN-LABEL PHASE II CLINICAL TRIAL

Rheumatology ◽

10.1093/rheumatology/kez063.026 ◽

2019 ◽

Vol 58 (Supplement_2) ◽

Cited By ~ 1

Author(s):

Seerapani Gopaluni ◽

Donna Goymer ◽

Mark McClure ◽

Hugh Cahill ◽

Elizabeth Broadhurst ◽

...

Keyword(s):

Clinical Trial ◽

Phase Ii ◽

Systemic Vasculitis ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Phase ◽

Primary Systemic Vasculitis

Download Full-text

Long-term Efficacy and Safety of Mepolizumab in Patients With Severe Eosinophilic Asthma: A Multi-center, Open-label, Phase IIIb Study

Clinical Therapeutics ◽

10.1016/j.clinthera.2016.07.010 ◽

2016 ◽

Vol 38 (9) ◽

pp. 2058-2070.e1 ◽

Cited By ~ 112

Author(s):

Njira Lugogo ◽

Christian Domingo ◽

Pascal Chanez ◽

Richard Leigh ◽

Martyn J. Gilson ◽

...

Keyword(s):

Efficacy And Safety ◽

Open Label ◽

Eosinophilic Asthma ◽

Severe Eosinophilic Asthma ◽

Term Efficacy ◽

Phase Iiib ◽

Open Label Phase

Download Full-text

Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial

Diabetes Obesity and Metabolism ◽

10.1111/dom.13922 ◽

2019 ◽

Vol 22 (4) ◽

pp. 540-548 ◽

Cited By ~ 4

Author(s):

Eiichi Araki ◽

Hirotaka Watada ◽

Yasuko Uchigata ◽

Osamu Tomonaga ◽

Hitomi Fujii ◽

...

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text

Review for "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial"

10.1111/dom.13922/v1/review3 ◽

2019 ◽

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text

Decision letter for "Efficacy and safety of dapagliflozin in Japanese patients with inadequately controlled type 1 diabetes (DEPICT‐5): 52‐week results from a randomized, open‐label, phase III clinical trial"

10.1111/dom.13922/v1/decision1 ◽

2019 ◽

Keyword(s):

Clinical Trial ◽

Type 1 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Open Label ◽

Phase Iii Clinical Trial ◽

Open Label Phase

Download Full-text

Efficacy and Safety of Bavituximab in Combination with Sorafenib in Advanced Hepatocellular Carcinoma: A Single-Arm, Open-Label, Phase II Clinical Trial

Targeted Oncology ◽

10.1007/s11523-019-00663-3 ◽

2019 ◽

Vol 14 (5) ◽

pp. 541-550 ◽

Cited By ~ 2

Author(s):

Ali A. Mokdad ◽

Hao Zhu ◽

Muhammad S. Beg ◽

Yull Arriaga ◽

Jonathan E. Dowell ◽

...

Keyword(s):

Hepatocellular Carcinoma ◽

Clinical Trial ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Advanced Hepatocellular Carcinoma ◽

Efficacy And Safety ◽

Open Label ◽

Open Label Phase

Download Full-text

Efficacy and safety of apatinib in advanced soft tissue sarcoma: A multi-center, open-label phase II clinical trial.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.11546 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 11546-11546

Author(s):

Wenxi Yu ◽

Zhengfu Fan ◽

Jing Chen ◽

Hong-Mei Zhang ◽

Xing Zhang ◽

...

Keyword(s):

Clinical Trial ◽

Soft Tissue ◽

Soft Tissue Sarcoma ◽

Phase Ii ◽

Phase Ii Clinical Trial ◽

Efficacy And Safety ◽

Open Label ◽

Advanced Soft Tissue Sarcoma ◽

Open Label Phase

Download Full-text